American International Group, Inc. Immuno Gen, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $5,980 - $14,376	-480 Reduced 0.4%	119,145 $3.53 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $39,494 - $55,695	2,803 Added 2.4%	119,625 $1.9 Million
Q2 2023 Aug 04, 2023	BUY	$3.75 - $20.05 $49,492 - $264,619	13,198 Added 12.74%	116,822 $2.2 Million
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $7,567 - $10,145	2,062 Added 2.03%	103,624 $397,000
Q4 2022 Feb 10, 2023	SELL	$4.55 - $6.31 $1,683 - $2,334	-370 Reduced 0.36%	101,562 $503,000
Q3 2022 Nov 14, 2022	BUY	$4.48 - $6.47 $6,455 - $9,323	1,441 Added 1.43%	101,932 $487,000
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $19,577 - $35,798	-6,215 Reduced 5.82%	100,491 $452,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $6,773 - $11,893	1,590 Added 1.51%	106,706 $508,000
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $14,938 - $23,587	-3,145 Reduced 2.91%	105,116 $780,000
Q3 2021 Nov 12, 2021	SELL	$5.02 - $6.59 $6,144 - $8,066	-1,224 Reduced 1.12%	108,261 $614,000
Q2 2021 Aug 13, 2021	SELL	$5.79 - $8.6 $13,374 - $19,866	-2,310 Reduced 2.07%	109,485 $722,000
Q1 2021 May 07, 2021	BUY	$6.5 - $10.53 $28,652 - $46,416	4,408 Added 4.1%	111,795 $906,000
Q4 2020 Feb 12, 2021	BUY	$3.7 - $7.66 $17,197 - $35,603	4,648 Added 4.52%	107,387 $693,000
Q3 2020 Nov 04, 2020	SELL	$3.45 - $4.89 $8,059 - $11,423	-2,336 Reduced 2.22%	102,739 $370,000
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $16,762 - $26,961	5,049 Added 5.05%	105,075 $483,000
Q1 2020 May 04, 2020	BUY	$2.12 - $6.8 $19,525 - $62,628	9,210 Added 10.14%	100,026 $341,000
Q4 2019 Feb 05, 2020	SELL	$2.25 - $5.8 $1,721 - $4,437	-765 Reduced 0.84%	90,816 $464,000
Q3 2019 Nov 08, 2019	SELL	$2.22 - $3.39 $1,414 - $2,159	-637 Reduced 0.69%	91,581 $222,000
Q2 2019 Aug 13, 2019	BUY	$1.8 - $3.3 $1,216 - $2,230	676 Added 0.74%	92,218 $200,000
Q1 2019 May 06, 2019	SELL	$2.41 - $5.91 $7,150 - $17,534	-2,967 Reduced 3.14%	91,542 $248,000
Q4 2018 Feb 13, 2019	SELL	$3.94 - $9.7 $2,860 - $7,042	-726 Reduced 0.76%	94,509 $454,000
Q3 2018 Nov 09, 2018	BUY	$8.6 - $11.26 $101,024 - $132,271	11,747 Added 14.07%	95,235 $902,000
Q2 2018 Aug 08, 2018	BUY	$9.52 - $12.15 $186,972 - $238,626	19,640 Added 30.76%	83,488 $812,000
Q1 2018 May 07, 2018	SELL	$6.7 - $12.95 $22,994 - $44,444	-3,432 Reduced 5.1%	63,848 $672,000
Q4 2017 Feb 09, 2018	BUY	$5.07 - $7.92 $55,004 - $85,924	10,849 Added 19.23%	67,280 $431,000
Q3 2017 Nov 09, 2017	BUY	$5.4 - $8.47 $304,727 - $477,970	56,431	56,431 $432,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account